These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2582411)

  • 1. Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.
    DeFreitas EC; Dietzschold B; Koprowski H
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3425-9. PubMed ID: 2582411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D.
    Wyckoff JH; Osmand AP; Eisenberg RJ; Cohen GH; Rouse BT
    Immunobiology; 1988 May; 177(2):134-48. PubMed ID: 2456985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge.
    Eisenberg RJ; Cerini CP; Heilman CJ; Joseph AD; Dietzschold B; Golub E; Long D; Ponce de Leon M; Cohen GH
    J Virol; 1985 Dec; 56(3):1014-7. PubMed ID: 2999419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation.
    Heber-Katz E; Hollosi M; Dietzschold B; Hudecz F; Fasman GD
    J Immunol; 1985 Aug; 135(2):1385-90. PubMed ID: 2409148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individuals.
    Damhof RA; Drijfhout JW; Scheffer AJ; Wilterdink JB; Welling GW; Welling-Wester S
    Arch Virol; 1993; 130(1-2):187-93. PubMed ID: 8503783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping T cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-Ia interaction.
    Heber-Katz E; Valentine S; Dietzschold B; Burns-Purzycki C
    J Exp Med; 1988 Feb; 167(2):275-87. PubMed ID: 2450157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
    Cohen GH; Dietzschold B; Ponce de Leon M; Long D; Golub E; Varrichio A; Pereira L; Eisenberg RJ
    J Virol; 1984 Jan; 49(1):102-8. PubMed ID: 6197535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.
    Geerligs HJ; Feijlbrief M; Bolk M; Bos CA; Drijfhout JW; Welling GW; Welling-Wester S
    Arch Virol; 1990; 114(3-4):251-8. PubMed ID: 2173527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
    Kohl S; Strynadka NC; Hodges RS; Pereira L
    J Clin Invest; 1990 Jul; 86(1):273-8. PubMed ID: 2164044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
    Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.